Jiang Huafang, Xu Chaolong, Duan Ruoyu, Liu Zhimei, Ren Xiaotun, Li Jiuwei, Chen Chunhong, Wang Hongmei, Han Tongli, Tian Xiaojuan, Duan Xin, Song Minhan, Li Tongyue, Fang Fang
Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Department of Pediatrics, WeiFang Maternal and Child Health Hospital, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Weifang, China.
J Hum Genet. 2025 Jan;70(1):25-32. doi: 10.1038/s10038-024-01291-0. Epub 2024 Sep 3.
Mutations in IBA57 disrupt iron-sulfur clusters maturation, causing a rare mitochondrial disease. Clinical manifestations vary from neonatal lethality to childhood-onset spastic paraparesis, yet the ethnic heterogeneity and natural history remain unclear, necessitating further exploration. This study aimed to delineate the genotype-phenotype correlation of IBA57 mutations by analyzing diverse clinical presentations. We report 11 Chinese patients and include literature-reported cases, totaling 61 patients enrolled for analysis. Clinical, neuroimaging, genetic, and disease progression information were collected. Among these, 46 presented as multiple mitochondrial dysfunctions syndrome 3 (MMDS3), with 58.7% originating from Chinese population. Based on disease course, we propose three clinical subtypes: neonatal, infant and childhood subtypes. Neonatal cases universally displayed hypotonia and respiratory distress at presentation, deceased within three months. Most infancy and childhood cases exhibited developmental regression and impaired motor function. Cavitating leukoencephalopathy was a typical neuroimaging finding in MMDS3 patients. The c.286 T > C mutation was reported in 85.2% of Chinese patients. A significantly lower mortality rate was observed compared to the non-Chinese group (P = 0.002), with a survival rate exceeding 90% at 5 years, indicating a relatively stable disease progression. Fifteen cases from three families manifested the spastic paraplegia 74 phenotype, demonstrating normal development before onset, with common clinical manifestations including spastic paraplegia (14/15), visual impairment (10/13), and peripheral neuropathy (9/13). In conclusion, this study indicates a hotspot mutation in Chinese and analyses the disease progression with different clinical subtypes.
IBA57基因的突变会破坏铁硫簇的成熟过程,从而引发一种罕见的线粒体疾病。其临床表现从新生儿致死到儿童期起病的痉挛性截瘫各不相同,但种族异质性和自然病史仍不清楚,需要进一步探索。本研究旨在通过分析不同的临床表现来阐明IBA57基因突变与表型的相关性。我们报告了11例中国患者,并纳入文献报道的病例,共61例患者纳入分析。收集了临床、神经影像学、遗传学和疾病进展信息。其中,46例表现为多重线粒体功能障碍综合征3(MMDS3),58.7%来自中国人群。基于病程,我们提出了三种临床亚型:新生儿型、婴儿型和儿童型。新生儿病例在发病时普遍表现为肌张力减退和呼吸窘迫,在三个月内死亡。大多数婴儿期和儿童期病例表现出发育倒退和运动功能受损。空洞性白质脑病是MMDS3患者典型的神经影像学表现。在中国患者中,85.2%报告有c.286 T > C突变。与非中国组相比,观察到的死亡率显著较低(P = 0.002),5年生存率超过90%,表明疾病进展相对稳定。来自三个家庭的15例患者表现出痉挛性截瘫74型的表型,发病前发育正常,常见临床表现包括痉挛性截瘫(14/15)、视力障碍(10/13)和周围神经病变(9/13)。总之,本研究指出了中国人群中的一个热点突变,并分析了不同临床亚型的疾病进展情况。